Therefore, this study provides novel evidence demonstrating that PRPF8 is associated with the aggressiveness and poor prognosis of HCC, thereby suggesting that PRPF8 inhibition could be particularly useful in HCC, a steadily increasing type of cancer for which therapeutic options are scarce1. The gene discussed is PRPF8; the disease is cancer.